Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Esophageal Neoplasms 2Neoplasms 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 271Specimen Handling 266pembrolizumab 233Cyclophosphamide 219Radiotherapy 208Nivolumab 169Cisplatin 165Biopsy 152Carboplatin 145Radiosurgery 131fludarabine 125Blood Specimen Collection 120Gemcitabine 113Paclitaxel 109Surveys and Questionnaires 108Standard of Care 106venetoclax 97Dexamethasone 95Bevacizumab 93Radiation 87Rituximab 83Capecitabine 81Cytarabine 80Oxaliplatin 77Drug Therapy 76Doxorubicin 75Ipilimumab 74durvalumab 73fludarabine phosphate 70atezolizumab 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × TP protocol × 90 days × Clear all
NCT06532539 2026-04-24

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
30 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

NCT06143748 2026-04-23

EC-CRT-006

Sun Yat-sen University

Phase 2 Active not recruiting
46 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT06964568 2026-04-17

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Fudan University

Phase 3 Recruiting
452 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡